Transporters and renal drug elimination.

Carrier-mediated processes, often referred to as transporters, play key roles in the reabsorption and secretion of many endogenous and xenobiotic compounds by the kidney. The renal proximal tubule is the primary site of active transport for a wide variety of substrates, including organic anions/cations, peptides, and nucleosides. During the past decade, significant advances in molecular identification and characterization of transporter proteins have been made. Although it is generally noted that these transporters significantly contribute to renal drug handling and variability in drug disposition, the extent of our knowledge regarding the specific roles of such transporters in drug disposition and drug-drug interactions remains, for the most part, limited. In this review, we summarize recent progress in terms of molecular and functional characterization of renal transporters and their clinical relevance to drug therapy.

[1]  R. Burk,et al.  Immunologic distribution of an organic anion transport protein in rat liver and kidney. , 1996, The American journal of physiology.

[2]  M. Hediger,et al.  Human Intestinal H+/Peptide Cotransporter , 1995, The Journal of Biological Chemistry.

[3]  A. Duncan,et al.  Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.

[4]  Balázs Sarkadi,et al.  The role of multidrug transporters in drug availability, metabolism and toxicity. , 2003, Toxicology letters.

[5]  V. Ganapathy,et al.  Identity of the Organic Cation Transporter OCT3 as the Extraneuronal Monoamine Transporter (uptake2) and Evidence for the Expression of the Transporter in the Brain* , 1998, The Journal of Biological Chemistry.

[6]  T. Cihlar,et al.  The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1. , 1999, Molecular pharmacology.

[7]  M. Okuda,et al.  Functional characterization of the rat multispecific organic anion transporter OAT1 mediating basolateral uptake of anionic drugs in the kidney , 1998, FEBS letters.

[8]  Y. Sugiyama,et al.  Functional Analysis of a Canalicular Multispecific Organic Anion Transporter Cloned from Rat Liver* , 1998, The Journal of Biological Chemistry.

[9]  H. Daniel,et al.  An update on renal peptide transporters. , 2003, American journal of physiology. Renal physiology.

[10]  F. Lang,et al.  Electrogenic Properties and Substrate Specificity of the Polyspecific Rat Cation Transporter rOCT1* , 1996, The Journal of Biological Chemistry.

[11]  D. Miller,et al.  Mechanisms mediating renal secretion of organic anions and cations. , 1993, Physiological reviews.

[12]  V. Schuster,et al.  Cloning of the human kidney PAH transporter: narrow substrate specificity and regulation by protein kinase C. , 1999, American journal of physiology. Renal physiology.

[13]  M C Willingham,et al.  Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[14]  D. H. Sweet,et al.  Expression Cloning and Characterization of ROAT1 , 1997, The Journal of Biological Chemistry.

[15]  G. Rappold,et al.  Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter , 1998, Nature Neuroscience.

[16]  Y. Kanai,et al.  Cloning and Characterization of a Novel Multispecific Organic Anion Transporter * , 1997 .

[17]  J. Kim,et al.  Molecular Cloning and Characterization of Multispecific Organic Anion Transporter 4 Expressed in the Placenta* , 2000, The Journal of Biological Chemistry.

[18]  F. Russel,et al.  The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP. , 2002, Journal of the American Society of Nephrology : JASN.

[19]  P. Jansen,et al.  The role of the canalicular multispecific organic anion transporter in the disposal of endo- and xenobiotics. , 1994, Pharmacology & therapeutics.

[20]  Y. Tanigawara,et al.  Role of P-glycoprotein in renal tubular secretion of digoxin in the isolated perfused rat kidney. , 1993, The Journal of pharmacology and experimental therapeutics.

[21]  H. Takikawa,et al.  ATP-dependent Transport of Bile Salts by Rat Multidrug Resistance-associated Protein 3 (Mrp3)* , 2000, The Journal of Biological Chemistry.

[22]  H. Endou,et al.  Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. , 2002, Journal of Pharmacology and Experimental Therapeutics.

[23]  M. Romero,et al.  Expression cloning of a mammalian proton-coupled oligopeptide transporter , 1994, Nature.

[24]  J. Nezu,et al.  Molecular and Functional Identification of Sodium Ion-dependent, High Affinity Human Carnitine Transporter OCTN2* , 1998, The Journal of Biological Chemistry.

[25]  D. Keppler,et al.  Transport of monoglucuronosyl and bisglucuronosyl bilirubin by recombinant human and rat multidrug resistance protein 2 , 1999, Hepatology.

[26]  D. H. Sweet,et al.  rOCT2 is a basolateral potential-driven carrier, not an organic cation/proton exchanger. , 1999, American journal of physiology. Renal physiology.

[27]  P. Meier,et al.  Transport function and hepatocellular localization of mrp6 in rat liver. , 2000, Molecular pharmacology.

[28]  J. Nezu,et al.  Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. , 1999, The Journal of pharmacology and experimental therapeutics.

[29]  M. Kool,et al.  Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. , 1998, The Journal of clinical investigation.

[30]  P. Swaan,et al.  Molecular mechanism for the relative binding affinity to the intestinal peptide carrier. Comparison of three ACE-inhibitors: enalapril, enalaprilat, and lisinopril. , 1995, Biochimica et biophysica acta.

[31]  M. Lebwohl,et al.  Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Wijnholds,et al.  Characterization of the MRP4- and MRP5-mediated Transport of Cyclic Nucleotides from Intact Cells* , 2003, The Journal of Biological Chemistry.

[33]  F. Lang,et al.  Monoamine neurotransmitter transport mediated by the polyspecific cation transporter rOCT1 , 1996, FEBS letters.

[34]  V. Schuster,et al.  Identification and characterization of a prostaglandin transporter. , 1995, Science.

[35]  Heinz Bönisch,et al.  Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3 , 2002, British journal of pharmacology.

[36]  Y. Sugiyama,et al.  Biliary excretion of pravastatin in rats: contribution of the excretion pathway mediated by canalicular multispecific organic anion transporter. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[37]  A. Aguzzi,et al.  Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier. , 2000, The Journal of pharmacology and experimental therapeutics.

[38]  J. H. Beijnen,et al.  Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs , 1994, Cell.

[39]  H. Kusuhara,et al.  Reduced folate derivatives are endogenous substrates for cMOAT in rats. , 1998, The American journal of physiology.

[40]  G. Peters,et al.  MRP3, an organic anion transporter able to transport anti-cancer drugs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[41]  D. Keppler,et al.  The Multidrug Resistance Protein 5 Functions as an ATP-dependent Export Pump for Cyclic Nucleotides* , 2000, The Journal of Biological Chemistry.

[42]  K. Giacomini,et al.  Cloning and functional expression of a human liver organic cation transporter. , 1997, Molecular pharmacology.

[43]  D. Miller,et al.  Renal secretion of organic anions and cations. , 1996, Kidney international.

[44]  M. Hediger,et al.  Molecular cloning of PEPT 2, a new member of the H+/peptide cotransporter family, from human kidney. , 1995, Biochimica et biophysica acta.

[45]  A. Enomoto,et al.  Role of human organic anion transporter 4 in the transport of ochratoxin A. , 2002, Biochimica et biophysica acta.

[46]  A. Wolkoff,et al.  The modified dipeptide, enalapril, an angiotensin‐converting enzyme inhibitor, is transported by the rat liver organic anion transport protein , 1998, Hepatology.

[47]  P. Meier,et al.  Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver. , 1995, Gastroenterology.

[48]  S. Takenoshita,et al.  Immuno-localization of H+/peptide cotransporter in rat digestive tract. , 1996, Biochemical and biophysical research communications.

[49]  J. A. Nelson,et al.  A transfected cell model for the renal toxin transporter, rOCT2. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[50]  H. Koepsell,et al.  Molecular Pharmacology of Organic Cation Transporters in Kidney , 1999, The Journal of Membrane Biology.

[51]  P. Meier,et al.  Polyspecific substrate uptake by the hepatic organic anion transporter Oatp1 in stably transfected CHO cells. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[52]  M. Kool,et al.  Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport , 2000, British Journal of Cancer.

[53]  A. Enomoto,et al.  Interactions of human organic anion as well as cation transporters with indoxyl sulfate. , 2003, European journal of pharmacology.

[54]  E. Holtzman,et al.  Molecular cloning and characterization of two novel human renal organic anion transporters (hOAT1 and hOAT3). , 1999, Biochemical and biophysical research communications.

[55]  D. Keppler,et al.  Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in dubin‐johnson syndrome , 2000, Hepatology.

[56]  P. Meier,et al.  Uptake of the mycotoxin ochratoxin A in liver cells occurs via the cloned organic anion transporting polypeptide. , 1996, The Journal of pharmacology and experimental therapeutics.

[57]  G. Kruh,et al.  Structure and in vitro substrate specificity of the murine multidrug resistance-associated protein. , 1996, Biochemistry.

[58]  N. Obermüller,et al.  Transport of Monoamine Transmitters by the Organic Cation Transporter Type 2, OCT2* , 1998, The Journal of Biological Chemistry.

[59]  V. Ganapathy,et al.  β-Lactam Antibiotics as Substrates for OCTN2, an Organic Cation/Carnitine Transporter* , 2000, The Journal of Biological Chemistry.

[60]  J. Wijnholds,et al.  Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5. , 2003, Molecular pharmacology.

[61]  M. Kool,et al.  Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. , 1997, Cancer research.

[62]  H. Yawo,et al.  Molecular Characterization and Tissue Distribution of a New Organic Anion Transporter Subtype (oatp3) That Transports Thyroid Hormones and Taurocholate and Comparison with oatp2* , 1998, The Journal of Biological Chemistry.

[63]  Y. Sugiyama,et al.  Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR. , 1997, The American journal of physiology.

[64]  Y. Tanigawara,et al.  Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1). , 1992, The Journal of pharmacology and experimental therapeutics.

[65]  A. Sekine,et al.  Catalog of 238 variations among six human genes encoding solute carriers (hSLCs) in the Japanese population , 2002, Journal of Human Genetics.

[66]  D. Keppler,et al.  ATP-dependent para-aminohippurate transport by apical multidrug resistance protein MRP2. , 2000, Kidney international.

[67]  V. Ganapathy,et al.  Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. , 1999, The Journal of pharmacology and experimental therapeutics.

[68]  A. Wolkoff,et al.  Organic Anion Transporting Polypeptide Mediates Organic Anion/HCO3 − Exchange* , 1997, The Journal of Biological Chemistry.

[69]  M. Breen,et al.  pABC11 (Also Known as MOAT-C and MRP5), a Member of the ABC Family of Proteins, Has Anion Transporter Activity but Does Not Confer Multidrug Resistance When Overexpressed in Human Embryonic Kidney 293 Cells* , 1999, The Journal of Biological Chemistry.

[70]  V. Ganapathy,et al.  cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. , 1998, Biochemical and biophysical research communications.

[71]  R. Kim,et al.  Uptake of enalapril and expression of organic anion transporting polypeptide 1 in zonal, isolated rat hepatocytes. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[72]  Y. Kanai,et al.  Identification of multispecific organic anion transporter 2 expressed predominantly in the liver , 1998, FEBS letters.

[73]  Y. Kanai,et al.  Rat multispecific organic anion transporter 1 (rOAT1) transports zidovudine, acyclovir, and other antiviral nucleoside analogs. , 2000, The Journal of pharmacology and experimental therapeutics.

[74]  D. Keppler,et al.  ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2. , 1997, The Biochemical journal.

[75]  S. Yao,et al.  Cloning and functional expression of a complementary DNA encoding a mammalian nucleoside transport protein. , 1994, The Journal of biological chemistry.

[76]  T. Cantz,et al.  MRP2, a human conjugate export pump, is present and transports fluo 3 into apical vacuoles of Hep G2 cells. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[77]  H. Daniel,et al.  Transport characteristics of differently charged cephalosporin antibiotics in oocytes expressing the cloned intestinal peptide transporter PepT1 and in human intestinal Caco-2 cells. , 1996, The Journal of pharmacology and experimental therapeutics.

[78]  J. Beijnen,et al.  Drug Interactions Between Antiretroviral Drugs and Comedicated Agents , 2003, Clinical pharmacokinetics.

[79]  D. Keppler,et al.  Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. , 1999, Biochimica et biophysica acta.

[80]  Maristela L Onozato,et al.  Interaction of human and rat organic anion transporter 2 with various cephalosporin antibiotics. , 2003, European journal of pharmacology.

[81]  H. Saito,et al.  Characterization of stably transfected kidney epithelial cell line expressing rat H+/peptide cotransporter PEPT1: localization of PEPT1 and transport of beta-lactam antibiotics. , 1997, The Journal of pharmacology and experimental therapeutics.

[82]  K. Hirsch‐Ernst,et al.  Modulation of P-glycoprotein and mdr1b mRNA expression by growth factors in primary rat hepatocyte culture. , 1995, Biochemical and biophysical research communications.

[83]  D. Roden,et al.  The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. , 1998, The Journal of clinical investigation.

[84]  M. Namer,et al.  CLINICAL AND PHARMACOKINETIC EVIDENCE OF A LIFE-THREATENING INTERACTION BETWEEN METHOTREXATE AND KETOPROFEN , 1986, The Lancet.

[85]  A. Guo,et al.  Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir. , 1998, Biochemical and biophysical research communications.

[86]  F. Lang,et al.  Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. , 1998, Molecular pharmacology.

[87]  P. Meier,et al.  Multispecific amphipathic substrate transport by an organic anion transporter of human liver. , 1996, Journal of hepatology.

[88]  B. Sikic,et al.  Pharmacological considerations in the modulation of multidrug resistance. , 1996, European journal of cancer.

[89]  Conrad C. Huang,et al.  Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function. , 2002, Pharmacogenetics.

[90]  A. Enomoto,et al.  Interactions of Human Organic Anion Transporters and Human Organic Cation Transporters with Nonsteroidal Anti-Inflammatory Drugs , 2002, Journal of Pharmacology and Experimental Therapeutics.

[91]  M. Takano,et al.  H+ coupled uphill transport of aminocephalosporins via the dipeptide transport system in rabbit intestinal brush-border membranes. , 1986, The Journal of biological chemistry.

[92]  M. Willingham,et al.  Expression, transport properties, and chromosomal location of organic anion transporter subtype 3. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[93]  P. Dawson,et al.  Fruit juices inhibit organic anion transporting polypeptide–mediated drug uptake to decrease the oral availability of fexofenadine , 2002, Clinical pharmacology and therapeutics.

[94]  D. Gründemann,et al.  Catecholamine transport by the organic cation transporter type 1 (OCT1) , 1998, British journal of pharmacology.

[95]  S. Masuda,et al.  Cloning and Functional Characterization of a Novel Rat Organic Anion Transporter Mediating Basolateral Uptake of Methotrexate in the Kidney* , 1996, The Journal of Biological Chemistry.

[96]  H. Endou,et al.  The multispecific organic anion transporter (OAT) family , 2000, Pflügers Archiv.

[97]  J. A. Nelson,et al.  Role of organic cation transporters in the renal secretion of nucleosides. , 2000, Biochemical pharmacology.

[98]  V. Schuster,et al.  Estradiol 17 beta-D-glucuronide is a high-affinity substrate for oatp organic anion transporter. , 1996, The American journal of physiology.

[99]  M. Fromm,et al.  Genetic polymorphisms of the human MDR1 drug transporter. , 2003, Annual review of pharmacology and toxicology.

[100]  Y. Sugiyama,et al.  Temocaprilat, a novel angiotensin-converting enzyme inhibitor, is excreted in bile via an ATP-dependent active transporter (cMOAT) that is deficient in Eisai hyperbilirubinemic mutant rats (EHBR). , 1997, The Journal of pharmacology and experimental therapeutics.

[101]  J. Nezu,et al.  Studies on Functional Sites of Organic Cation/Carnitine Transporter OCTN2 (SLC22A5) Using a Ser467Cys Mutant Protein , 2002, Journal of Pharmacology and Experimental Therapeutics.

[102]  K. Giacomini,et al.  Transporters involved in the elimination of drugs in the kidney: organic anion transporters and organic cation transporters. , 2001, Journal of pharmaceutical sciences.

[103]  H. Saito,et al.  Inhibitory effect of anti-diabetic agents on rat organic anion transporter rOAT1. , 2000, European journal of pharmacology.

[104]  K. Giacomini,et al.  The interaction of n-tetraalkylammonium compounds with a human organic cation transporter, hOCT1. , 1999, The Journal of pharmacology and experimental therapeutics.

[105]  A. Enomoto,et al.  Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors. , 2002, The Journal of pharmacology and experimental therapeutics.

[106]  F. Baas,et al.  Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[107]  K. Giacomini,et al.  Functional and Molecular Characteristics of Na+-dependent Nucleoside Transporters , 1997, Pharmaceutical Research.

[108]  H. Coley,et al.  Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein. , 2003, Cancer control : journal of the Moffitt Cancer Center.

[109]  Hiroshi Suzuki,et al.  Characterization of the Transport Properties of Cloned Rat Multidrug Resistance-associated Protein 3 (MRP3)* , 1999, The Journal of Biological Chemistry.

[110]  D. Miller,et al.  Basolateral localization of organic cation transporter 2 in intact renal proximal tubules. , 2000, American journal of physiology. Renal physiology.

[111]  M. Gottesman,et al.  The effect of ion channel blockers, immunosuppressive agents, and other drugs on the activity of the multi‐drug transporter , 1993, International journal of cancer.

[112]  R. Kim MDR1 single nucleotide polymorphisms: multiplicity of haplotypes and functional consequences. , 2002, Pharmacogenetics.

[113]  F. Russel,et al.  Mechanisms and clinical implications of renal drug excretion* , 2001, Drug metabolism reviews.

[114]  Y. Sugiyama,et al.  Expression and localization of the multidrug resistance-associated protein 3 in rat small and large intestine. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[115]  H. Endou,et al.  Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transporters. , 2001, European journal of pharmacology.

[116]  V. Schuster,et al.  Mechanism of Prostaglandin E2 Transport across the Plasma Membrane of HeLa Cells and Xenopus Oocytes Expressing the Prostaglandin Transporter “PGT”* , 1998, The Journal of Biological Chemistry.

[117]  W. Hwu,et al.  A founder mutation (R254X) of SLC22A5 (OCTN2) in Chinese primary carnitine deficiency patients , 2002, Human mutation.

[118]  K. Cundy Clinical Pharmacokinetics of the Antiviral Nucleotide Analogues Cidofovir and Adefovir , 1999, Clinical pharmacokinetics.

[119]  S. Masuda,et al.  Interactions of nonsteroidal anti-inflammatory drugs with rat renal organic anion transporter, OAT-K1. , 1997, The Journal of pharmacology and experimental therapeutics.

[120]  David E. Smith,et al.  Competitive Inhibition of Glycylsarcosine Transport by Enalapril in Rabbit Renal Brush Border Membrane Vesicles: Interaction of ACE Inhibitors with High-Affinity H+/Peptide Symporter , 1999, Pharmaceutical Research.

[121]  F. Baas,et al.  Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. , 1993, Cancer research.

[122]  Joseph W. Polli,et al.  Role of P-Glycoprotein on the CNS Disposition of Amprenavir (141W94), an HIV Protease Inhibitor , 1999, Pharmaceutical Research.

[123]  M. Takano,et al.  cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2. , 1996, Biochemical and biophysical research communications.

[124]  T. Cihlar,et al.  Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. , 2000, Journal of the American Society of Nephrology : JASN.

[125]  M. Takano,et al.  Carrier-mediated transport of cephalexin via the dipeptide transport system in rat renal brush-border membrane vesicles. , 1984, Biochimica et biophysica acta.

[126]  V. Ganapathy,et al.  Cloning and Functional Characterization of a Potential-sensitive, Polyspecific Organic Cation Transporter (OCT3) Most Abundantly Expressed in Placenta* , 1998, The Journal of Biological Chemistry.

[127]  V. Schuster,et al.  Cloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA(hPGT). , 1996, The Journal of clinical investigation.

[128]  Y. Sugiyama,et al.  cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3) 1 , 1998 .

[129]  T. Visser,et al.  Identification of thyroid hormone transporters. , 1999, Biochemical and biophysical research communications.

[130]  R. Evers,et al.  Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione , 1999 .

[131]  K. Giacomini,et al.  Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa). , 1998, The Journal of pharmacology and experimental therapeutics.

[132]  T. Cantz,et al.  Expression of the apical conjugate export pump, Mrp2, in the polarized hepatoma cell line, WIF‐B , 1998, Hepatology.

[133]  H. Endou,et al.  Immunolocalization of multispecific organic anion transporters, OAT1, OAT2, and OAT3, in rat kidney. , 2002, Journal of the American Society of Nephrology : JASN.

[134]  H. Koepsell,et al.  Organic cation transporters in intestine, kidney, liver, and brain. , 1998, Annual review of physiology.

[135]  A. Takeuchi,et al.  Role of kidney-specific organic anion transporters in the urinary excretion of methotrexate. , 2001, Kidney international.

[136]  A Takeuchi,et al.  Multispecific substrate recognition of kidney-specific organic anion transporters OAT-K1 and OAT-K2. , 2001, The Journal of pharmacology and experimental therapeutics.

[137]  Y. Kanai,et al.  The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1. , 1999, The Journal of pharmacology and experimental therapeutics.

[138]  W. Pardridge,et al.  Differential kinetics of transport of 2',3'-dideoxyinosine and adenosine via concentrative Na+ nucleoside transporter CNT2 cloned from rat blood-brain barrier. , 2001, The Journal of pharmacology and experimental therapeutics.

[139]  A. Takeuchi,et al.  Trans-stimulation effects of folic acid derivatives on methotrexate transport by rat renal organic anion transporter, OAT-K1. , 2000, The Journal of pharmacology and experimental therapeutics.

[140]  G. Tsujimoto,et al.  Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter , 1999, Nature Genetics.

[141]  H. Saito,et al.  Recognition of L-amino acid ester compounds by rat peptide transporters PEPT1 and PEPT2. , 1999, The Journal of pharmacology and experimental therapeutics.

[142]  J. Beijnen,et al.  Assessing Safety and Efficacy of Directed P-Glycoprotein Inhibition to Improve the Pharmacokinetic Properties of Saquinavir Coadministered with Ritonavir , 2003, Journal of Pharmacology and Experimental Therapeutics.

[143]  G R Wilkinson,et al.  OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[144]  M. Erion,et al.  Isolation of a family of organic anion transporters from human liver and kidney. , 2001, Biochemical and biophysical research communications.

[145]  P. Meier,et al.  Localization of organic anion transporting polypeptide 4 (Oatp4) in rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3 , 2001, Pflügers Archiv.

[146]  H. Koepsell,et al.  Drug excretion mediated by a new prototype of polyspecific transporter , 1994, Nature.

[147]  A. Somogyi,et al.  Effect of H2 antagonists on the differential secretion of triamterene and its sulfate conjugate metabolite by the isolated perfused rat kidney. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[148]  T. Abe,et al.  Printed in U.S.A. Copyright © 2001 by The Endocrine Society Identification of Thyroid Hormone Transporters in Humans: Different Molecules Are Involved in a , 2000 .

[149]  S. Masuda,et al.  Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs. , 1998, The Journal of pharmacology and experimental therapeutics.

[150]  C. Boyd,et al.  Proton-coupled oligopeptide transport by rat renal cortical brush border membrane vesicles: a functional analysis using ACE inhibitors to determine the isoform of the transporter. , 1998, Biochimica et biophysica acta.

[151]  U. Brinkmann,et al.  ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2. , 2001, Pharmacogenomics.

[152]  K. Ullrich Renal Transporters for Organic Anions and Organic Cations. Structural Requirements for Substrates , 1997, The Journal of Membrane Biology.

[153]  V. Ganapathy,et al.  Differential Recognition of β-Lactam Antibiotics by Intestinal and Renal Peptide Transporters, PEPT 1 and PEPT 2 (*) , 1995, The Journal of Biological Chemistry.

[154]  H. Saito,et al.  Recognition of β-lactam antibiotics by rat peptide transporters, PEPT1 and PEPT2, in LLC-PK1 cells. , 1997, American journal of physiology. Renal physiology.

[155]  Y. Sugiyama,et al.  Transport of temocaprilat into rat hepatocytes: role of organic anion transporting polypeptide. , 1998, The Journal of pharmacology and experimental therapeutics.

[156]  V. Ganapathy,et al.  Interaction of anionic cephalosporins with the intestinal and renal peptide transporters PEPT 1 and PEPT 2. , 1997, Biochimica et biophysica acta.

[157]  G R Wilkinson,et al.  Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[158]  H. Saito,et al.  Dipeptide transporters in apical and basolateral membranes of the human intestinal cell line Caco-2. , 1993, The American journal of physiology.

[159]  F. Döring,et al.  Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications. , 1998, The Journal of clinical investigation.

[160]  V. Ganapathy,et al.  Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta. , 2000, Biochimica et biophysica acta.

[161]  Jos H Beijnen,et al.  Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs , 2002, AIDS.

[162]  D. Keppler,et al.  cDNA Cloning of the Hepatocyte Canalicular Isoform of the Multidrug Resistance Protein, cMrp, Reveals a Novel Conjugate Export Pump Deficient in Hyperbilirubinemic Mutant Rats* , 1996, The Journal of Biological Chemistry.

[163]  V. Sasseville,et al.  A Novel Human Hepatic Organic Anion Transporting Polypeptide (OATP2) , 1999, The Journal of Biological Chemistry.

[164]  D. Barlow,et al.  Cloning of the mouse and human solute carrier 22a3 (Slc22a3/SLC22A3) identifies a conserved cluster of three organic cation transporters on mouse chromosome 17 and human 6q26-q27. , 1999, Genomics.

[165]  A. Takeuchi,et al.  Cloning and functional characterization of a new multispecific organic anion transporter, OAT-K2, in rat kidney. , 1999, Molecular pharmacology.

[166]  H. Koepsell,et al.  Localization of organic cation transporters OCT1 and OCT2 in rat kidney. , 2000, American journal of physiology. Renal physiology.

[167]  H. Kusuhara,et al.  Functional characterization of rat organic anion transporter 2 in LLC-PK1 cells. , 2001, The Journal of pharmacology and experimental therapeutics.

[168]  P. Meier,et al.  Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver , 1997, Hepatology.

[169]  N. Ballatori,et al.  Identification of Glutathione as a Driving Force and Leukotriene C4 as a Substrate for oatp1, the Hepatic Sinusoidal Organic Solute Transporter* , 1998, The Journal of Biological Chemistry.

[170]  Y. Tanigawara,et al.  Simvastatin and lovastatin, but not pravastatin, interact with MDR1 , 2002, The Journal of pharmacy and pharmacology.

[171]  M. Hediger,et al.  Differential Recognition of ACE Inhibitors in Xenopus Laevis Oocytes Expressing Rat PEPT1 and PEPT2 , 2000, Pharmaceutical Research.

[172]  T. Abe,et al.  In vitro study of the functional expression of organic anion transporting polypeptide 3 at rat choroid plexus epithelial cells and its involvement in the cerebrospinal fluid-to-blood transport of estrone-3-sulfate. , 2003, Molecular pharmacology.

[173]  V. Ganapathy,et al.  Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2. , 1998, Biochemical and biophysical research communications.

[174]  B. Sarkadi,et al.  Loss of ATP-dependent Transport Activity in Pseudoxanthoma Elasticum-associated Mutants of Human ABCC6 (MRP6)* , 2002, The Journal of Biological Chemistry.

[175]  H. Koepsell,et al.  The affinity of the organic cation transporter rOCT1 is increased by protein kinase C-dependent phosphorylation. , 2000, Journal of the American Society of Nephrology : JASN.

[176]  J. Nezu,et al.  Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. , 2000, Biochemical and biophysical research communications.

[177]  M. Fromm,et al.  Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein. , 2000, The Journal of pharmacology and experimental therapeutics.

[178]  K. Kohno,et al.  Mutations in the Canalicular Multispecific Organic Anion Transporter (cMOAT) Gene, a Novel ABC Transporter, in Patients with Hyperbilirubinemia II/Dubin-Johnson Syndrome , 1998 .

[179]  F. Russel,et al.  Molecular aspects of renal anionic drug transport. , 2002, Annual review of physiology.

[180]  G. Groothuis,et al.  Polyspecific organic anion transporting polypeptides mediate hepatic uptake of amphipathic type II organic cations. , 1999, The Journal of pharmacology and experimental therapeutics.

[181]  R. Kim Transporters and xenobiotic disposition. , 2002, Toxicology.

[182]  H. Kusuhara,et al.  Molecular Cloning and Characterization of a New Multispecific Organic Anion Transporter from Rat Brain* , 1999, The Journal of Biological Chemistry.

[183]  Y. Asano,et al.  P-glycoprotein-mediated drug secretion in mouse proximal tubule perfused in vitro. , 2001, Journal of the American Society of Nephrology : JASN.

[184]  S. Masuda,et al.  Cellular and molecular aspects of drug transport in the kidney. , 2000, Kidney international.

[185]  D. Smith,et al.  Noncompetitive inhibition of glycylsarcosine transport by quinapril in rabbit renal brush border membrane vesicles: effect on high-affinity peptide transporter. , 1998, The Journal of pharmacology and experimental therapeutics.

[186]  F. Lang,et al.  Cloning and characterization of two human polyspecific organic cation transporters. , 1997, DNA and cell biology.

[187]  David J. Buttler,et al.  Genomic structure and in vivo expression of the human organic anion transporter 1 (hOAT1) gene. , 2000, Biochemical and biophysical research communications.

[188]  S. Yao,et al.  Molecular cloning and functional expression of cDNAs encoding a human Na+-nucleoside cotransporter (hCNT1). , 1997, The American journal of physiology.

[189]  D. Keppler,et al.  Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. , 1999, Molecular pharmacology.

[190]  K. Giacomini,et al.  Kinetic and selectivity differences between rodent, rabbit, and human organic cation transporters (OCT1). , 2000, The Journal of pharmacology and experimental therapeutics.

[191]  J. Nezu,et al.  Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. , 1999, The Journal of pharmacology and experimental therapeutics.

[192]  A. Schinkel,et al.  BBB Transport and P-glycoprotein Functionality Using MDR1A (-/-) and Wild-Type Mice. Total Brain Versus Microdialysis Concentration Profiles of Rhodamine-123 , 1998, Pharmaceutical Research.

[193]  J. Nezu,et al.  Cloning and characterization of a novel human pH‐dependent organic cation transporter, OCTN1 , 1997, FEBS letters.

[194]  K. Brouwer,et al.  Altered hepatobiliary disposition of acetaminophen glucuronide in isolated perfused livers from multidrug resistance-associated protein 2-deficient TR(-) rats. , 2000, The Journal of pharmacology and experimental therapeutics.

[195]  V. Schuster,et al.  Transient expression of oatp organic anion transporter in mammalian cells: identification of candidate substrates. , 1996, The American journal of physiology.

[196]  T. Futami,et al.  Interaction of β-Lactam Antibiotics with H+/Peptide Cotransporters in Rat Renal Brush-Border Membranes , 1998 .

[197]  U. Brinkmann,et al.  Identification of genetic variations of the human organic cation transporter hOCT1 and their functional consequences. , 2002, Pharmacogenetics.

[198]  R. Hyde,et al.  Molecular Identification and Characterization of Novel Human and Mouse Concentrative Na+-Nucleoside Cotransporter Proteins (hCNT3 and mCNT3) Broadly Selective for Purine and Pyrimidine Nucleosides (System cib)* , 2001, The Journal of Biological Chemistry.

[199]  D. Keppler,et al.  Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane , 1999, Hepatology.

[200]  J. Schuetz,et al.  MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs , 1999, Nature Medicine.

[201]  R. Evers,et al.  Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions. , 2000, Molecular pharmacology.

[202]  A. Bröer,et al.  Functional and pharmacological characterization of human Na(+)-carnitine cotransporter hOCTN2. , 2000, American journal of physiology. Renal physiology.

[203]  Y. Minemoto,et al.  p-aminohippuric acid transport at renal apical membrane mediated by human inorganic phosphate transporter NPT1. , 2000, Biochemical and biophysical research communications.

[204]  D. Keppler,et al.  Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules. , 1997, Journal of the American Society of Nephrology : JASN.

[205]  A. Klein-Szanto,et al.  Analysis of the MRP4 drug resistance profile in transfected NIH3T3 cells. , 2000, Journal of the National Cancer Institute.

[206]  E. Seidman,et al.  Expression and localization of organic cation/carnitine transporter OCTN2 in Caco-2 cells. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[207]  Liyue Huang,et al.  Adenosine triphosphate–dependent transport of estradiol‐17β(β‐d‐glucuronide) in membrane vesicles by MDR1 expressed in insect cells , 1998 .

[208]  N. Longo,et al.  Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[209]  P. Borst,et al.  Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. , 1995, The Journal of clinical investigation.

[210]  Y. Kanai,et al.  Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. , 2001, Molecular pharmacology.

[211]  P. Borst,et al.  Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[212]  T. Futami,et al.  Effect of clarithromycin on renal excretion of digoxin: Interaction with P‐glycoprotein , 1998, Clinical pharmacology and therapeutics.

[213]  Zhe-Sheng Chen,et al.  Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine. , 2001, The Journal of biological chemistry.

[214]  K. Roberg,et al.  Molecular cloning and characterization of a novel liver-specific transport protein. , 1994, Journal of cell science.

[215]  M. Kool,et al.  Mutations in ABCC6 cause pseudoxanthoma elasticum , 2000, Nature Genetics.

[216]  Wolfgang Sadee,et al.  5′-Amino Acid Esters of Antiviral Nucleosides, Acyclovir, and AZT Are Absorbed by the Intestinal PEPT1 Peptide Transporter , 1998, Pharmaceutical Research.

[217]  C. Cass,et al.  Recent advances in the molecular biology of nucleoside transporters of mammalian cells , 1998 .

[218]  V Ganapathy,et al.  Improvement of L-dopa absorption by dipeptidyl derivation, utilizing peptide transporter PepT1. , 1998, Journal of pharmaceutical sciences.

[219]  Y. Kanai,et al.  Transport of ochratoxin A by renal multispecific organic anion transporter 1. , 1998, The Journal of pharmacology and experimental therapeutics.

[220]  D. Gründemann,et al.  Selective substrates for non-neuronal monoamine transporters. , 1999, Molecular pharmacology.

[221]  H. Endou,et al.  Characterization of Methotrexate Transport and Its Drug Interactions with Human Organic Anion Transporters , 2002, Journal of Pharmacology and Experimental Therapeutics.

[222]  Hori Ryohei,et al.  Transport of bestatin in rat renal brush-border membrane vesicles , 1993 .

[223]  V. Ganapathy,et al.  Mutations in Novel Organic Cation Transporter (OCTN2), an Organic Cation/Carnitine Transporter, with Differential Effects on the Organic Cation Transport Function and the Carnitine Transport Function* , 1999, The Journal of Biological Chemistry.

[224]  P. Meier,et al.  Expression cloning of a rat liver Na(+)-independent organic anion transporter. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[225]  L Landmann,et al.  Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. , 2001, Gastroenterology.

[226]  D. Keppler,et al.  A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2). , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[227]  E. Takeda,et al.  Hepatic sinusoidal membrane transport of anionic drugs mediated by anion transporter Npt1. , 1998, The Journal of pharmacology and experimental therapeutics.

[228]  D. Gründemann,et al.  Agmatine Is Efficiently Transported by Non-Neuronal Monoamine Transporters Extraneuronal Monoamine Transporter (EMT) and Organic Cation Transporter 2 (OCT2) , 2003, Journal of Pharmacology and Experimental Therapeutics.

[229]  J. Wijnholds,et al.  MRP6 (ABCC6) Detection in Normal Human Tissues and Tumors , 2002, Laboratory Investigation.

[230]  Y. Sugiyama,et al.  Methotrexate is excreted into the bile by canalicular multispecific organic anion transporter in rats. , 1997, Cancer research.

[231]  W. E. Mol,et al.  Mechanisms for the hepatic uptake of organic cations. Studies with the muscle relaxant vecuronium in isolated rat hepatocytes. , 1988, The Journal of pharmacology and experimental therapeutics.

[232]  Tianxin Yang,et al.  Localization of PEPT1 and PEPT2 proton-coupled oligopeptide transporter mRNA and protein in rat kidney. , 1999, American journal of physiology. Renal physiology.

[233]  J. Mackey,et al.  Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine. , 1998, Molecular membrane biology.

[234]  Y. Kanai,et al.  Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. , 1999, American journal of physiology. Renal physiology.

[235]  M. Hediger,et al.  hPepT1-mediated epithelial transport of bacteria-derived chemotactic peptides enhances neutrophil-epithelial interactions. , 1998, The Journal of clinical investigation.

[236]  V. Ganapathy,et al.  Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2. , 2000, Journal of pharmaceutical sciences.

[237]  D. Meijer,et al.  A multispecific uptake system for taurocholate, cardiac glycosides and cationic drugs in the liver. , 1992, Biochemical pharmacology.

[238]  M. Kool,et al.  Tissue Distribution and Induction of Human Multidrug Resistant Protein 3 , 2002, Laboratory Investigation.

[239]  A. Takeuchi,et al.  Functional analysis of rat renal organic anion transporter OAT‐K1: bidirectional methotrexate transport in apical membrane , 1999, FEBS letters.

[240]  P. Bosma,et al.  Congenital Jaundice in Rats with a Mutation in a Multidrug Resistance-Associated Protein Gene , 1996, Science.

[241]  Y. Sugiyama,et al.  Both cMOAT/MRP2 and another unknown transporter(s) are responsible for the biliary excretion of glucuronide conjugate of the nonpeptide angiotensin II antagonist, telmisaltan. , 2000, Drug metabolism and disposition: the biological fate of chemicals.